Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
6,713,803
-
Total 13F shares
-
756
-
Share change
-
0
-
Total reported value
-
$1,536
-
Price per share
-
$2.03
-
Number of holders
-
3
Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q4 2025
As of 31 Dec 2025,
Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
756 shares.
The largest 3 holders included
SIGNATUREFD, LLC, Blue Trust, Inc., and Kozak & Associates, Inc..
This page lists
3
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.